Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126576301 | 12657630 | 1 | I | 20151027 | 20160809 | 20160816 | 20160816 | EXP | US-PFIZER INC-2016381777 | PFIZER | 72.00 | YR | M | Y | 0.00000 | 20160816 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126576301 | 12657630 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | 600 MG, 2X/DAY | U | 20235 | 600 | MG | BID | ||||||
| 126576301 | 12657630 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 15 MG, 1X/DAY | 140 | MG | Y | 0 | 15 | MG | CAPSULE | QD | |||
| 126576301 | 12657630 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 5 MG, 1X/DAY | 140 | MG | Y | 0 | 5 | MG | CAPSULE | QD | |||
| 126576301 | 12657630 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 20 MG, 1X/DAY | 140 | MG | Y | 0 | 20 | MG | CAPSULE | QD | |||
| 126576301 | 12657630 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNK | 0 | |||||||||||
| 126576301 | 12657630 | 6 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 126576301 | 12657630 | 7 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126576301 | 12657630 | 8 | C | TRAMADOL. | TRAMADOL | 1 | UNK | 0 | |||||||||||
| 126576301 | 12657630 | 9 | C | MVI | VITAMINS | 1 | UNK | 0 | |||||||||||
| 126576301 | 12657630 | 10 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 126576301 | 12657630 | 11 | C | ALBUTEROL HFA | ALBUTEROL SULFATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126576301 | 12657630 | 1 | Neuralgia |
| 126576301 | 12657630 | 2 | Plasma cell myeloma |
| 126576301 | 12657630 | 5 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126576301 | 12657630 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126576301 | 12657630 | Confusional state | |
| 126576301 | 12657630 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126576301 | 12657630 | 2 | 201301 | 0 | ||
| 126576301 | 12657630 | 3 | 201405 | 0 | ||
| 126576301 | 12657630 | 4 | 20151021 | 20151027 | 0 | |
| 126576301 | 12657630 | 5 | 20151021 | 0 |